drugset / Trial / NCT04031755
A Proof-of-Concept Study of Minocycline in Autism
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of the study is to determine if Minocycline shows initial evidence of efficacy, safety, and tolerability in youth with Autism Spectrum Disorder ages 12 to 22 years.
Timeline
- Start
- 2019-04-19
- Primary completion
- 2020-10-30
- Completion
- 2020-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minocycline | Small molecule | 100 mg | — |